About us
ADDP is designed for inspiring international and interdisciplinary exchange at the forefront of drug research and to accelerate the cooperation for new drug development. We provide online talk series for scientists, researchers and decision makers from all over the world to debate on the latest scientific advances in the field of drug discovery and deliver that help to shape current and future challenges in drug research. Drug Discovery Platform will be attracting senior strategic decision-makers with top-level speakers, interactive round-tables, knowledge-sharing panel sessions, in-depth workshops and superb networking. The sprawling show hosts over 120 companies, so you will be sure to find a service provider to help set you up for success.

Why Attend

Our Speakers

Solutions at ADDP 2021
πŸ”· Licensing
πŸ”· Research & Development
πŸ”· Biomarker Validation
πŸ”· Pharmacogenetic Testing
πŸ”· Gene Expression Profiling Solutions
πŸ”· Preclinical
πŸ”· DNA & RNA Analysis
πŸ”· Biochemistry
πŸ”· Data Management Technology
πŸ”· ADMUPI (Toxicology)
πŸ”· Genomics
πŸ”· Lead Optimalisation and Profiling, HTSΒ  Β  Β  Β  Β  Β  Β  Β  Β  Technology
πŸ”· Covering Biological studies
πŸ”· Molecular Biology
πŸ”· PK/PD
πŸ”· ln licensing/out-licensing discovery projectsΒ  Β  Β  Β  Β  proprietary technologies
πŸ”· Protein identification Services
πŸ”· Discovery Outsourcing Services
πŸ”· Lead Generation
πŸ”· Bio-informatics
πŸ”· Structural Biology
πŸ”· Drug Discovery Technology Platforms
πŸ”· Transgenesis Services
πŸ”· Combinatorial Chemistry
πŸ”· Medicinal Chemistry
πŸ”· DNA Sequencing Services
πŸ”· Antibody Engineering
πŸ”· Digital imaging Technology
πŸ”· Principal Scientists
πŸ”· Reagents Technology
πŸ”· imaging/biomarker service/collaboration
πŸ”· Screening and Profiling Services
πŸ”· Target identification & Validation
πŸ”· Pharmacology
πŸ”· High Throughput Screening

Target Audience

πŸ”· VP of Chemistry
πŸ”· Principal Scientist
πŸ”· Senior Director Functional Genomics
πŸ”· VP Pharmacology & Preclinical PK/PD

πŸ”· Head of Drug Design
πŸ”· CSO
πŸ”· VP Translational Medicine
πŸ”· Director of Discovery Strategy Portfolio

πŸ”· CEO
πŸ”· VP Target Discovery & Assessment
πŸ”· Senior Director Discovery Research

πŸ”· Director Discovery Alliances
πŸ”· Head Pharmacology & Toxicology
πŸ”· Executive Director Chemistry

Agenda

πŸ”· 1:15 – 1:30 (GMT) CHAIRMAN’S WELCOME REMARKS

πŸ”· 1:30 – 2:00 Presentation no.1:

Investigating Advanced AI Technology for Protein Design:Β 

  • Recent advances in automated protein design and its future challenges
  • Looking at developments in protein design creating novel biomolecules with desired functions
  • Exploring the advanced AI technology and methodology
  • Explaining the value behind the project and the potential in creating new biomaterials

πŸ”· 2:00 – 2:30 Presentation no.2:

RNA-Targeting Small Molecule Drugs: Designing and Optimizing Small Molecules to Modulate Diverse RNA Motifs and Pathways:

  • Exploring diversity of RNA Targets
  • Tools and Technologies for Medicinal Chemistry
  • An overview of design and optimization of RNA Modulators
  • Enabling Technologies for Targeting RNA-Protein Interactions
0
CONTINENT
0
COUNTRIES
0
INDUSTRIES
0
+
BUYERS

Our Partners

Media Partners